Global Rare Disease Genetic Testing Market Size study, by Disease Type (Neurological Disease, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Di

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,950	285 Pages	Bizwit Research & Consulting	September, 2024	BIZW19146690

Best Price Guarantee
Price	from $4,950
Length	285 Pages
Publisher	Bizwit Research & Consulting
Published Date	September, 2024
SKU	BIZW19146690

Global Rare Disease Genetic Testing Market Size study, by Disease Type (Neurological Disease, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Disease, Others), by Technology (Next-Generation Sequencing (NGS), Whole Exome Sequencing, Whole Genome Sequencing, Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping), by Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests), by End-Use (Research Laboratories & CROs, Hospitals & Clinics, Diagnostic Laboratories) and Regional Forecasts 2022-2032

The global rare disease genetic testing market size was valued at USD 887.79 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 14.30% from 2024 to 2032. Rare disease genetic testing involves analysing an individual's DNA to identify genetic mutations responsible for rare conditions, which affect a small percentage of the population. These tests help diagnose diseases that are often challenging to identify due to their rarity and diverse presentations. Applications of rare disease genetic testing include confirming clinical diagnoses, informing treatment decisions, guiding family planning, and enabling early intervention. It also facilitates research into the genetic basis of rare diseases, potentially leading to the development of new therapies. Additionally, genetic testing can aid in identifying carriers of genetic mutations, helping at-risk families make informed health decisions.
The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes significantly drives the demand for rare disease genetic testing. With the aging global population, the prevalence of these diseases is increasing, necessitating more pathological examinations and diagnostic tests to guide treatment plans and improve patient outcomes. Advancements in genetic testing technologies, such as next-generation sequencing (NGS) and whole-exome sequencing (WES), enhance the accuracy, speed, and affordability of these tests. These technological innovations facilitate comprehensive analysis of genetic mutations, making it possible to diagnose previously challenging rare diseases accurately. Furthermore, the growing awareness and adoption of personalized medicine, which tailors treatment to individual genetic profiles, are propelling the market. Personalized medicine relies heavily on precise diagnostic information from genetic testing to identify specific genetic mutations responsible for rare diseases, enabling targeted and effective treatments. Additionally, emerging markets, particularly in Asia-Pacific and Latin America, present substantial growth opportunities due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness of genetic disorders. However, the market faces significant challenges, such as the high costs of genetic testing, which can be prohibitive for many patients, particularly in low-income regions. Limited access to advanced testing facilities and the absence of reimbursement policies further restricts the widespread adoption of genetic testing for rare diseases. Addressing these barriers is crucial to ensure that genetic testing is accessible and affordable for all individuals affected by rare diseases.
In 2023, North America dominated the global rare disease genetic testing market, holding a substantial share of over 47%. This dominance can be attributed to the high incidence of rare diseases, extensive disease registries, a significant number of R&D facilities for ultra-rare diseases, and substantial investments in disease diagnosis. Conversely, the Asia Pacific region is poised to experience the fastest growth, with a projected CAGR of 18% during the forecast period. This growth is driven by increasing healthcare infrastructure development, rising disposable incomes, and growing awareness of genetic disorders in the region.
Major market players included in this report are:
Quest Diagnostics Inc.
Centogene N.V.
Invitae Corp.
3billion, Inc.
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer, Inc.
Realm IDX, Inc.
Macrogen, Inc.
Baylor Genetics
Color Genomics, Inc.
Health Network Laboratories
PreventionGenetics
The detailed segments and sub-segment of the market are explained below:
By Disease Type:
• Neurological Disease
• Immunological Disorders
• Hematology Diseases
• Endocrine & Metabolism Diseases
• Cancer
• Musculoskeletal Disorders
• Cardiovascular Disorders (CVDs)
• Dermatology Disease
• Others
By Technology:
• Next-Generation Sequencing (NGS)
• Whole Exome Sequencing
• Whole Genome Sequencing
• Array Technology
• PCR-based Testing
• FISH
• Sanger Sequencing
• Karyotyping
By Specialty:
• Molecular Genetic Tests
• Chromosomal Genetic Tests
• Biochemical Genetic Tests
By End-Use:
• Research Laboratories & CROs
• Hospitals & Clinics
• Diagnostic Laboratories
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Chapter 1. Global Rare Disease Genetic Testing Market Executive Summary: 1.1. Global Rare Disease Genetic Testing Market Size & Forecast (2022-2032); 1.2. Regional Summary; 1.3. Segmental Summary; 1.3.1. By Disease Type; 1.3.2. By Technology; 1.3.3. By Specialty; 1.3.4. By End-Use; 1.4. Key Trends; 1.5. Recession Impact; 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Rare Disease Genetic Testing Market Definition and Research Assumptions: 2.1. Research Objective; 2.2. Market Definition; 2.3. Research Assumptions; 2.3.1. Inclusion & Exclusion; 2.3.2. Limitations; 2.3.3. Supply Side Analysis; 2.3.3.1. Availability; 2.3.3.2. Infrastructure; 2.3.3.3. Regulatory Environment; 2.3.3.4. Market Competition; 2.3.3.5. Economic Viability (Consumer’s Perspective); 2.3.4. Demand Side Analysis; 2.3.4.1. Regulatory frameworks; 2.3.4.2. Technological Advancements; 2.3.4.3. Environmental Considerations; 2.3.4.4. Consumer Awareness & Acceptance; 2.4. Estimation Methodology; 2.5. Years Considered for the Study; 2.6. Currency Conversion Rates
Chapter 3. Global Rare Disease Genetic Testing Market Dynamics: 3.1. Market Drivers; 3.1.1. Advancements in Genetic Testing Technologies; 3.1.2. Increased Awareness and Diagnosis of Rare Diseases; 3.1.3. Rising Prevalence of Rare Diseases; 3.2. Market Challenges; 3.2.1. High Costs and Limited Accessibility; 3.3. Market Opportunities; 3.3.1. Personalized Medicine; 3.3.2. Expansion in Emerging Markets
Chapter 4. Global Rare Disease Genetic Testing Market Industry Analysis: 4.1. Porter’s 5 Force Model; 4.1.1. Bargaining Power of Suppliers; 4.1.2. Bargaining Power of Buyers; 4.1.3. Threat of New Entrants; 4.1.4. Threat of Substitutes; 4.1.5. Competitive Rivalry; 4.1.6. Futuristic Approach to Porter’s 5 Force Model; 4.1.7. Porter’s 5 Force Impact Analysis; 4.2. PESTEL Analysis; 4.2.1. Political; 4.2.2. Economical; 4.2.3. Social; 4.2.4. Technological; 4.2.5. Environmental; 4.2.6. Legal; 4.3. Top investment opportunity; 4.4. Top winning strategies; 4.5. Disruptive Trends; 4.6. Industry Expert Perspective; 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Rare Disease Genetic Testing Market Size & Forecasts by Disease Type 2022-2032: 5.1. Segment Dashboard; 5.2. Global Rare Disease Genetic Testing Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Million); 5.2.1. Neurological Disease; 5.2.2. Immunological Disorders; 5.2.3. Hematology Diseases; 5.2.4. Endocrine & Metabolism Diseases; 5.2.5. Cancer; 5.2.6. Musculoskeletal Disorders; 5.2.7. Cardiovascular Disorders (CVDs); 5.2.8. Dermatology Disease; 5.2.9. Others
Chapter 6. Global Rare Disease Genetic Testing Market Size & Forecasts by Technology 2022-2032: 6.1. Segment Dashboard; 6.2. Global Rare Disease Genetic Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million); 6.2.1. Next-Generation Sequencing (NGS); 6.2.2. Whole Exome Sequencing; 6.2.3. Whole Genome Sequencing; 6.2.4. Array Technology; 6.2.5. PCR-based Testing; 6.2.6. FISH; 6.2.7. Sanger Sequencing; 6.2.8. Karyotyping
Chapter 7. Global Rare Disease Genetic Testing Market Size & Forecasts by Specialty 2022-2032: 7.1. Segment Dashboard; 7.2. Global Rare Disease Genetic Testing Market: Specialty Revenue Trend Analysis, 2022 & 2032 (USD Million); 7.2.1. Molecular Genetic Tests; 7.2.2. Chromosomal Genetic Tests; 7.2.3. Biochemical Genetic Tests
Chapter 8. Global Rare Disease Genetic Testing Market Size & Forecasts by End-Use 2022-2032: 8.1. Segment Dashboard; 8.2. Global Rare Disease Genetic Testing Market: End-Use Revenue Trend Analysis, 2022 & 2032 (USD Million); 8.2.1. Research Laboratories & CROs; 8.2.2. Hospitals & Clinics; 8.2.3. Diagnostic Laboratories
Chapter 9. Global Rare Disease Genetic Testing Market Size & Forecasts by Region 2022-2032: 9.1. North America Rare Disease Genetic Testing Market; 9.1.1. U.S. Rare Disease Genetic Testing Market; 9.1.1.1. Disease Type breakdown size & forecasts, 2022-2032; 9.1.1.2. Technology breakdown size & forecasts, 2022-2032; 9.1.1.3. Specialty breakdown size & forecasts, 2022-2032; 9.1.1.4. End-Use breakdown size & forecasts, 2022-2032; 9.1.2. Canada Rare Disease Genetic Testing Market; 9.2. Europe Rare Disease Genetic Testing Market; 9.2.1. U.K. Rare Disease Genetic Testing Market; 9.2.2. Germany Rare Disease Genetic Testing Market; 9.2.3. France Rare Disease Genetic Testing Market; 9.2.4. Spain Rare Disease Genetic Testing Market; 9.2.5. Italy Rare Disease Genetic Testing Market; 9.2.6. Rest of Europe Rare Disease Genetic Testing Market; 9.3. Asia-Pacific Rare Disease Genetic Testing Market; 9.3.1. China Rare Disease Genetic Testing Market; 9.3.2. India Rare Disease Genetic Testing Market; 9.3.3. Japan Rare Disease Genetic Testing Market; 9.3.4. Australia Rare Disease Genetic Testing Market; 9.3.5. South Korea Rare Disease Genetic Testing Market; 9.3.6. Rest of Asia Pacific Rare Disease Genetic Testing Market; 9.4. Latin America Rare Disease Genetic Testing Market; 9.4.1. Brazil Rare Disease Genetic Testing Market; 9.4.2. Mexico Rare Disease Genetic Testing Market; 9.4.3. Rest of Latin America Rare Disease Genetic Testing Market; 9.5. Middle East & Africa Rare Disease Genetic Testing Market; 9.5.1. Saudi Arabia Rare Disease Genetic Testing Market; 9.5.2. South Africa Rare Disease Genetic Testing Market; 9.5.3. Rest of Middle East & Africa Rare Disease Genetic Testing Market
Chapter 10. Competitive Intelligence: 10.1. Key Company SWOT Analysis; 10.1.1. Company 1; 10.1.2. Company 2; 10.1.3. Company 3; 10.2. Top Market Strategies; 10.3. Company Profiles; 10.3.1. Quest Diagnostics Inc.; 10.3.1.1. Key Information; 10.3.1.2. Overview; 10.3.1.3. Financial (Subject to Data Availability); 10.3.1.4. Product Summary; 10.3.1.5. Market Strategies; 10.3.2. Centogene N.V.; 10.3.3. Invitae Corp.; 10.3.4. 3billion, Inc.; 10.3.5. Arup Laboratories; 10.3.6. Eurofins Scientific; 10.3.7. Strand Life Sciences; 10.3.8. Ambry Genetics; 10.3.9. Perkin Elmer, Inc.; 10.3.10. Realm IDX, Inc.; 10.3.11. Macrogen, Inc.; 10.3.12. Baylor Genetics; 10.3.13. Color Genomics, Inc.; 10.3.14. Health Network Laboratories; 10.3.15. PreventionGenetics
Chapter 11. Research Process: 11.1. Research Process; 11.1.1. Data Mining; 11.1.2. Analysis; 11.1.3. Market Estimation; 11.1.4. Validation; 11.1.5. Publishing; 11.2. Research Attributes
List of Tables: TABLE 1. Global Rare Disease Genetic Testing market, report scope; TABLE 2. Global Rare Disease Genetic Testing market estimates & forecasts by Region 2022-2032 (USD Million); TABLE 3. Global Rare Disease Genetic Testing market estimates & forecasts by Disease Type 2022-2032 (USD Million); TABLE 4. Global Rare Disease Genetic Testing market estimates & forecasts by Technology 2022-2032 (USD Million); TABLE 5. Global Rare Disease Genetic Testing market estimates & forecasts by Specialty 2022-2032 (USD Million); TABLE 6. Global Rare Disease Genetic Testing market estimates & forecasts by End-Use 2022-2032 (USD Million); TABLE 7. Global Rare Disease Genetic Testing market by segment, estimates & forecasts, 2022-2032 (USD Million); TABLE 8. Global Rare Disease Genetic Testing market by region, estimates & forecasts, 2022-2032 (USD Million); TABLE 9. U.S. Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 10. Canada Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 11. U.K. Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 12. Germany Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 13. France Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 14. Spain Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 15. Italy Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 16. China Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 17. India Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 18. Japan Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 19. Australia Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); TABLE 20. South Korea Rare Disease Genetic Testing market estimates & forecasts, 2022-2032 (USD Million); This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures: FIGURE 1. Global Rare Disease Genetic Testing market, research methodology; FIGURE 2. Global Rare Disease Genetic Testing market, market estimation techniques; FIGURE 3. Global market size estimates & forecast methods.; FIGURE 4. Global Rare Disease Genetic Testing market, key trends 2023; FIGURE 5. Global Rare Disease Genetic Testing market, growth prospects 2022-2032; FIGURE 6. Global Rare Disease Genetic Testing market, porters 5 force model; FIGURE 7. Global Rare Disease Genetic Testing market, PESTEL analysis; FIGURE 8. Global Rare Disease Genetic Testing market, value chain analysis; FIGURE 9. Global Rare Disease Genetic Testing market by segment, 2022 & 2032 (USD Million); FIGURE 10. Global Rare Disease Genetic Testing market by region, 2022 & 2032 (USD Million); FIGURE 11. Global Rare Disease Genetic Testing market by Disease Type, 2022 & 2032 (USD Million); FIGURE 12. Global Rare Disease Genetic Testing market by Technology, 2022 & 2032 (USD Million); FIGURE 13. Global Rare Disease Genetic Testing market by Specialty, 2022 & 2032 (USD Million); FIGURE 14. Global Rare Disease Genetic Testing market by End-Use, 2022 & 2032 (USD Million); FIGURE 15. North America Rare Disease Genetic Testing market 2022 & 2032 (USD Million); FIGURE 16. Europe Rare Disease Genetic Testing market 2022 & 2032 (USD Million); FIGURE 17. Asia pacific Rare Disease Genetic Testing market 2022 & 2032 (USD Million); FIGURE 18. Latin America Rare Disease Genetic Testing market 2022 & 2032 (USD Million); FIGURE 19. Middle East & Africa Rare Disease Genetic Testing market 2022 & 2032 (USD Million); FIGURE 20. Global Rare Disease Genetic Testing market, company market share analysis (2023); This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.